Recent News
SMARTEST Trial Hopes to Improve Survival Times for Mesothelioma
Researchers are performing a clinical trial hoping that they can make pleural mesothelioma a more manageable, and even survivable, disease. The clinical trial is being done at Princess Margaret Cancer[…]
Galinpepimut-S Cancer Vaccine in Combination with Opdivo
Promising results from a study on pleural mesothelioma were recently released. The study found when patients were treated with a new combination treatment, patients lived longer and had a better[…]
More Asbestos is Entering the Country Despite Regulations
Growing levels of asbestos are coming into the United States, even though there is a push to tighten regulations and even ban the substance. The main user of asbestos, the[…]
Increasing Levels of Women are Dying from Mesothelioma
Over the past 20 years, the number of women dying from mesothelioma increased by 25 percent. This is happening even with less asbestos being used. Deaths in men have been[…]
Targeted Therapy is Showing Promising Results for Mesothelioma
Targeted research is advancing the treatment of pleural mesothelioma. Results from a study on a novel protein inhibitor known as tazemetostat (brand name Tazverik) were recently released. It is showing[…]
Vudalimab for the Treatment of Mesothelioma
The MD Anderson Cancer Center is conducting a study on an immunotherapy drug that is specifically for rare, advanced tumors. Pleural and peritoneal mesothelioma are both included in the study.[…]
Proton Beam Radiation Therapy Use Increases for Mesothelioma and Lung Cancer
Proton beam radiation therapy is growing in popularity for treating mesothelioma and lung cancer. A study in JAMA Oncology looked at the use of this radiation for treating different types[…]
Monoclonal Antibody Treatment was Found Not to be Effective on Pleural Mesothelioma
A phase II clinical trial comparing anetumab ravtansine to the chemotherapy drug vinorelbine did not have promising results for treating mesothelioma like researchers had hoped. Anetumab ravtansine is an immunotherapy[…]
High HITHOC Dosage for Pleural Mesothelioma Improves Survival
High doses of hyperthermic intrathoracic chemotherapy (HITHOC) help pleural mesothelioma patients. A recent study found that when HITHOC is administered at a high dose, survival rates improve and periods of[…]
Two Cytoreductive Surgeries Can Improve Survival for Peritoneal Mesothelioma Patients
If peritoneal mesothelioma patients undergo a second surgery after recurrence, they can improve their survival. Data from a retrospective review from Wake Forest Baptist Medical Center shows that cytoreductive surgery[…]
Skip to content